Cite

HARVARD Citation

    Ruf, S. et al. (2018). CNS progression during vinblastine or targeted therapies for high‐risk relapsed ALK‐positive anaplastic large cell lymphoma: A case series. Pediatric blood & cancer. 65 (6), p. n/a. [Online]. 
  
Back to record